Cancers Upcoming Events Announce Your Event Here

13–16 May 2018 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018)

Anaheim Convention Center, California, USA

Meet Us at The 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018) (Booth # 319), Anaheim, CA, USA, 13–16 May 2018

We will be attending The 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018), co-located with the TechConnect World Innovation Conference, Defense TechConnect Summit and Spring SBIR/STTR Conference. The event will attract more than 350 featured exhibitors and an expected crowd of more than 4000 attendees, including business executives, venture capitalists, politicians, s cientists and researchers from over 70 countries. Nanotech contains 38 symposiums and brings together specialists from a wide range of scientific fields, technology and business.

Representatives of the following open access journals will attend:

Sensors
Materials
Nanomaterials
Journal of Functional Biomaterials
Journal of Imaging
Sustainability
Fluids
Photonics
Electronics
Catalysts
Applied Sciences
Inventions
Diagnostics
Cancers
Journal of Low Power Electronics and Applications
Designs
Pharmaceuticals
C
Inorganics
International Journal of Environmental Research and Public Health
Machines
Pharmaceutics
Journal of Manufacturing and Materials Processing
Actuators
Robotics
Energies
Biosensors
Chemosensors
Membranes
Coatings
Micromachines

If you will also attend this conference, please feel free to stop by our booth (Booth # 319). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit:

https://www.techconnectworld.com/Nanotech2018/

24–25 May 2018 3rd Annual Advances in Immuno-Oncology Congress

London, UK

Oxford Global is proud to present the 3rd Annual Advances in Immuno-Oncology Congress taking place on 24–25 May 2018 in London, UK, featuring over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate.

Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.

6 interactive streams:

  • Discovery of Immuno-Oncology Therapies
  • Translational Immuno-Oncology
  • Genomics in Cancer Immunotherapy and Precision Medicine
  • Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
  • Immuno-Oncology Therapeutics Approaches: Clinical Research and Clinical Trials
  • Microbiome in Immuno-Oncology

View the Agenda here: http://bit.ly/2oJlVB7

Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

Free Pre-Congress Live Webinars

Novel Checkpoint Inhibitors & Strategies for Combined Modality Treatment
Hosted by Geert Mudde, Founder and Chief Scientific Officer, TYG Oncology Ltd.
Register today, for free: http://bit.ly/2mGZNmO

Personalised Medicine and Immuno-Oncology
Hosted by Agnete Fredriksen, Chief Scientific Officer, Vaccibody
Register today, for free: http://bit.ly/2rigNFh

Can’t make the dates? Still register and a copy of the webinar recording can be sent to you.

For further information about the programme, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

http://bit.ly/2oJlVB7

7–8 June 2018 Oxford Global’s 19th Annual Drug Discovery Summit

Berlin, Germany

Join Oxford Global’s 19th Annual Drug Discovery Summit on the 7- 8th June 2018 in Berlin, Germany to explore the latest innovations pushing industry to new heights. This congress will cover such areas as innovation, enabling technologies, new modalities and novel drug targets as well as covering key areas such as phenotypic screening, genome based drug discovery and small molecule drug discovery.

Bringing together over 300 senior level peers, the congress is once again co-located with our 6th Annual Discovery Chemistry and Drug Design Congress. Delegates can expect to hear updates on discovery, medicinal and computational chemistry as well as medicinal chemistry in drug design. New for 2018 we’ll be including deep dive sessions on DNA encoded libraries as well as presentations on data visualisation, protein-protein interactions and protein degradation.

VIEW AGENDA: http://bit.ly/2mqWK5m

Drug Discovery Summit Streams:

  • Drug Discovery Innovation and Strategies
  • Successful Phenotypic Drug Discovery and Other High Content Screening Tools
  • Novel Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
  • Genome Based Drug Discovery, Screening, Imaging & Target Discovery

Discovery Chemistry & Drug Design Congress Streams:

  • Discovery Chemistry, Medicinal and Computational Chemistry
  • Drug Discovery Enabled Technologies; DNA Encoded Libraries
  • Medicinal Chemistry and Drug Design: Novel Approaches

https://www.drugdiscovery-summit1.com/

7–8 June 2018 2nd Annual Microbiome Discovery and Development Congress

Berlin, Germany

Oxford Global is proud to present the 2nd Annual Microbiome Discovery and Development Congress, taking place on the 7-8th June 2018 in Berlin, Germany. The conference showcases world-class senior industry experts presenting case studies on the most exciting issues in the microbiome field, covering novel strategies in microbiome research, the latest therapeutic trends, and the challenges and opportunities involved in commercialising microbiome therapeutics.

View Agenda: http://bit.ly/2BOsODK

The congress will cover 2 areas focusing on:

  • Novel Strategies & Technologies for Microbiome Drug Discovery
  • Therapeutic Potential of the Microbiome
  • New for 2018! Workshop on commercialising microbiome therapeutics.

Further sessions will focus on subjects including bioinformatics, translational modelling, genomic approaches, IP concerns, investment in the microbiome, the gut-brain axis and autoimmune disorders. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

2018 Microbiome Webinar:      
Microbiome-Directed Therapeutics to tackle metabolic disorders        
Hosted by Sandrine Claus, Chief Scientific Officer, LNC Therapeutics     
Register for Free Now: http://bit.ly/2j0IqvO

For more information about our programme and to register for the congress, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk.

http://bit.ly/2BOsODK

11–12 June 2018 2nd Annual Precision Medicine Congress

Munich, Germany

Join Oxford Global for the 2nd Annual Precision Medicine Congress, 11-12 June 2018, Munich as our panel of over 40 world class speakers discuss the latest regulatory updates, biomarker developments, information technologies and companion diagnostics for personalized therapies.        

View Agenda: http://bit.ly/2BF20WZ

Across two days, our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine. Over 40 presentations and case studies focusing on the key developments in precision medicine regulation, biomarkers, clinical development, digital technologies and diagnostics.

4 interactive streams:

  • Precision Medicine, Regulation, Reimbursement and Targeted Therapy
  • Precision Medicine, Biomarkers and Clinical Development
  • Precision Medicine: Genomics, Data analysis and Big Data Management
  • Precision Medicine and Diagnostics Development

2018 Live Webinar:

Precision Medicine & Cancer Genomics – Clinical And Pharmaceutical Applications
Hosted by Dr Honey Reddi, The Jackson Laboratory and Dr Michael Menden, AstraZeneca.
Register for Free Now: http://bit.ly/2F8bytZ

2017 Free Webinar Recording:

Clinical Utility of Genomic Testing 
Hosted by Elaine Lyon, Professor, University of Utah & Medical Director of Molecular Genetics, ARUP Laboratories.
Download for Free: http://bit.ly/2B3TOOO

For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.

http://bit.ly/2BF20WZ

17–19 June 2018 20th Symposium on Infections in the Immunocompromised Host

Athens, Greece

We encourage all who are interested in the clinical practice and research on infections in immunocompromised host to attend the 20th ICHS Symposium in Athens, Greece June 17-19, 2018. Many symposia, plenary sessions, poster sessions will provide the attendee with opportunities to meet with outstanding leaders and clinical experts in the broad field of infectious diseases and immune-deficiencies while covering such diverse topics as new diagnostics,  infections in transplant recipients,  invasive fungal infections and resistance,  treatment of multi-resistant bacteria, infectious complications in immunocompromised children,  life-threatening infections and intensive care in neutropenic cancer patients ,antiviral and antifungal immune responses in compromised hosts,  prophylaxis and treatment of viral infections in immunocompromised hosts, and others.

http://www.ichs.org/2018-ICHS-Symposium

 

https://ichs2018.com/

11–13 October 2018 Melbourne International Joint Breast Congress - ASBD, 4th CoBrCa & BreastSurgANZ

Melbourne, Australia

Melbourne International Breast Congress - held jointly with Australasian Society for Breast Disease (ASBD), 4th World Congress on Controversies in Breast Cancer (CoBrCa) & Breast Surgeons of Australia & New Zealand (BreastSurgANZ) - Melbourne, Australia, October 11-13, 2018. As the main congress in the field of breast diseases in the Asia-Pacific region in 2018, it shouldn’t be missed! It will directly address key issues facing clinicians in their daily practice, including medical oncology, surgery, radiation oncology, pathology, reconstruction, breast imaging, & more. The collaboration will create a multi-faceted congress of interest to all involved in the treatment of breast disease.

http://melbournebreast2018.org/

Back to Top